ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.121,52
0,26%
S&P 500
5.473,23
0,77%
Dow Jones
38.778,10
0,49%
Euro vs US Dollar
1,07228
-0,16%
Bitcoin
65.612,23
-1,33%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Novavax Inc (NVAX)

  7. Novavax Inc (NVAX) News

NVAX Novavax Inc

13,90
-0,15 (-1,07%)
Vor Marktöffnung
Zuletzt aktualisiert: 11:01:50
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Novavax Inc NVAX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,15 -1,07% 13,90 11:01:50
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
14,05
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.6.202422:13EDGAR2Form 144 - Report of proposed sale of securities
14.6.202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202422:00EDGAR2Form 8-K - Current report
14.6.202420:05PRNUSNovavax Submits Application to U.S. FDA for Updated..
06.6.202413:00EDGAR2Form 8-K - Current report
05.6.202403:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30.5.202415:25PRNUSNovavax to Participate in 2024 Jefferies Global Healthcare..
23.5.202422:05EDGAR2Form 8-K - Current report
20.5.202420:42EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
20.5.202412:35GLOBEShah Capital Withdraws Proxy Campaign Against Re-Election of..
20.5.202412:09EDGAR2Form SC 13D/A - General statement of acquisition of..
16.5.202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.5.202423:02EDGAR2Form 144 - Report of proposed sale of securities
13.5.202422:10EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
13.5.202422:02PRNUSNovavax to Participate in BofA Securities 2024 Health Care..
13.5.202420:39EDGAR2Form 8-K - Current report
10.5.202414:07EDGAR2Form 8-K - Current report
10.5.202414:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.5.202414:02IHMARKETNEWSNovavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple..
10.5.202408:15PRNUSNovavax Reports First Quarter 2024 Financial Results and..
10.5.202408:00PRNUSNovavax and Sanofi Announce Co-exclusive Licensing Agreement..
08.5.202422:53EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
07.5.202423:21EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
07.5.202420:43EDGAR2Form SC 13D/A - General statement of acquisition of..
07.5.202415:25PRNUSNovavax to Host Conference Call to Discuss First Quarter..
07.5.202413:44IHMARKETNEWSTesla’s April Sales Down 18% in China, Amazon’s..
06.5.202422:43EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
06.5.202412:22GLOBEShah Capital Launches Campaign Urging Stockholders to Vote..
15.4.202412:00GLOBEShah Capital nominates two highly qualified independent..
01.4.202414:00PRNUSNovavax Presents Data on Updated COVID-19 Vaccine and..
06.3.202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:02PRNUSNovavax to Participate in TD Cowen's 44th Annual Health Care..
28.2.202414:07EDGAR2Form 8-K - Current report
28.2.202414:00PRNUSNovavax Reports Fourth Quarter and Full Year 2023 Financial..
28.2.202413:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23.2.202414:03IHMARKETNEWSGoldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in..
22.2.202412:02EDGAR2Form 8-K - Current report
22.2.202412:00PRNUSNovavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine..
20.2.202415:25PRNUSNovavax to Host Conference Call to Discuss Fourth Quarter..
31.1.202414:00EDGAR2Form 8-K - Current report
25.1.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202415:25EDGAR2Form 8-K - Current report
03.1.202415:25PRNUSNovavax to Participate in the 42nd Annual J.P. Morgan..
18.12.202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
NVAX
Novavax
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten